Elezanumab (Anti-RGMA)

Ask supplier a question | View on supplier's website

Elezanumab (Anti-RGMA) is a human monoclonal antibody that selectively targets repulsive guidance molecule A (RGMa). Elezanumab potently inhibited RGMa mediated BMP signalling via the SMAD1/5/8 pathway with IC50 of 97 pM. MW: 146.44 kD.

Supplier	Selleck Chemicals
Product #	A2370
Sku #	A2370-1mg*5
Pricing	1mg*5, $970.00

Feedback